4.235USD-2.76%Mkt Cap: 371.27M USDP/E: —Last update: 2026-06-01
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap371.27M USD
Enterprise Value284.29M USD
Revenue (TTM)49.59M USD
Gross Profit25.62M USD
Net Income (TTM)-209.47M USD
Revenue/Share0.6170 USD
Last Price4.235 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees102
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.64
PEG—
EV/EBITDA-1.67
EV/Revenue5.73
P/S7.67
P/B5.88
EPS (TTM)-2.52
EPS (Forward)-1.19
52W Range
4.0003% of range11.25
52W High11.25 USD
52W Low4.000 USD
Profitability
Gross Margin82.86%
Oper. Margin-240.46%
EBITDA Margin0.00%
Profit Margin-677.59%
ROE-366.23%
ROA-85.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-137.51M USD
CapEx (TTM)9.62M USD
FCF Margin-186.91%
FCF Yield-24.96%
Net Debt-96.20M USD
Net Debt/EBITDA0.57
Balance Sheet
Debt/Equity1.52
Current Ratio3.04
Quick Ratio2.87
Book Value/Sh0.7360 USD
Cash/Share2.067 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateJun 1, 2023
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)16.00 USD
Target Range14.00 USD – 18.00 USD
# Analysts8
Ownership
Shares Out.87.87M
Float70.40M
Insiders0.91%
Institutions93.57%
Short Interest
Short Ratio7.8d
Short % Float20.46%
Short % Out.20.34%
Shares Short17.87M
Short (prev mo.)17.42M
Technical
SMA 505.305 (-20.2%)
SMA 2007.370 (-42.5%)
Beta0.34
S&P 52W Chg27.70%
Avg Vol (30d)2.07M
Avg Vol (10d)2.12M
Technical Indicators
RSI (14)36.7
MACD-0.3712
MACD Signal-0.3663
MACD Hist.-0.0049
BB Upper6.166 USD
BB Middle4.795 USD
BB Lower3.423 USD
BB Width57.21%
ATR (14)0.3160 USD
Vol Ratio (20d)0.57x